Vanguard Asset Management’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$575K Buy
120,351
+30,769
+34% +$148K ﹤0.01% 2118
2026
Q2
$430K Hold
89,582
– – ﹤0.01% 2243
2026
Q1
$403K Buy
+89,582
New +$392K ﹤0.01% 2191

Other funds holding ABUS

Vanguard Asset Management's ABUS Position: Q3 2026 in Review

Vanguard Asset Management increased its Arbutus Biopharma (ABUS) stake by 34% in Q3 2026, buying an estimated $148K and bringing the position to 120,351 shares worth $575K. The position accounts for ﹤0.01% of the portfolio, ranked #2118.

Vanguard Asset Management first reported a position in ABUS in Q1 2026 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.

  • Vanguard Asset Management held 120,351 shares of Arbutus Biopharma worth $575K as of Q3 2026.
  • Vanguard Asset Management bought 30,769 Arbutus Biopharma shares in Q3 2026, an estimated $148K.
  • Arbutus Biopharma made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2118 holding.
  • Vanguard Asset Management first reported a position in Arbutus Biopharma in Q1 2026 and has held it in 3 quarters since.
  • 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.